With the use of hormone-altering chemicals and many other factors, infertility rates are on the rise, with the global incidence of 10-15%. Many may assume that this is a ‘women issue’ since all injections and tests are performed on a women’s body, but frankly, male factor infertility accounts for 40% of the cases.1 That is why it is so important now more than ever that advanced technology comes into play to support the tests needed to assess diagnoses of male infertility.
There are tests currently used to show whether one’s sperm has DNA damage or not, which is essential information to determine the sperm quality and health for reproduction. A new and modified test can now even assess the amount of DNA damage in sperm, if any, providing complete evaluation of sperm health. Sperm banks can also benefit from this novel information by accurately selecting high quality sperm during the selection process. Identifying viable sperm that leads to pregnancy may save intended parents one less heartache while trying to conceive.
Researchers in this study have compared the conventional tests with the new test results and have proven the greater accuracy of viable sperm for pregnancy. This new method of testing provides even further advantages, including short-time consumption, simple operation, high analytical sensitivity, and minimal instruments required. Having such tests available will not only improve the diagnoses of male infertility but advance fertility treatments across the world.
Read the full article and study here.